Interesting facts
Interesting Facts about N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
This complex compound represents a fascinating intersection of organic chemistry and pharmacology. Its intricate structure highlights the possibilities for drug development, especially in areas such as oncology and neurology. Here are several noteworthy aspects:
- Diverse Applications: Compounds with such complex structures are often explored for their potential as therapeutic agents. Their unique functionalities can lead to targeted therapies for various diseases.
- Biological Relevance: The presence of the indole moiety is particularly interesting, as it is commonly found in many biologically active compounds, including neurotransmitters and hormones.
- Chirality: The structural complexity indicates potential chirality, allowing for enantiomers that may exhibit different biological activities; hence, the stereochemistry of such compounds can be crucial in their application.
- Interdisciplinary Connections: The synthesis and characterization of this compound may involve multiple disciplines of science, including organic synthesis, medicinal chemistry, and computational modeling, underlining the collaborative nature of modern scientific research.
- Environmental Considerations: As with many new compounds, understanding the environmental impact, bioaccumulation, and degradation pathways is paramount in assessing safety and regulatory compliance.
In conclusion, N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide exemplifies the richness and complexity of chemical exploration. As scientists delve deeper into its properties, this compound has the potential to contribute significantly to the realm of pharmaceuticals and beyond.
Synonyms
NSC95090
5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman
113-15-5
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.)-
N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-
Ergoton-A [as succinate]
CHEMBL1982133
SCHEMBL18134607
BDBM86529
DTXSID90859201
XCGSFFUVFURLIX-UHFFFAOYSA-N
NSC_3251
CAS_113-15-5
NCI60_042117
XE180555
NS00002283
L000768
5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman #
12'-Hydroxy-2'-methyl-5'.alpha.-(phenylmethyl)ergotaman-3',6',18-trione
(5'.alpha.)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
Ergotaman-3',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.)-
WLN: T C6656 1A P GN LM CUTT & & J G1 EVM-DT B565 CO EVN HVNTJ BQ D1 G1R
Solubility Overview
The compound N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide (C27H23FN3O7) presents a unique profile in terms of solubility, influenced by its complex structure. Generally speaking, the solubility of organic compounds in solvents is determined by their polarity and functional groups.
Key Solubility Factors:
In conclusion, the solubility of this compound is likely to be variable based on the solvent choice. While it may show reasonable solubility in some polar solvents due to its functional groups, significant hydrophobic sections may limit solubility in others. Thus, for practical applications, conducting empirical experiments would be beneficial to ascertain its solubility characteristics accurately.